Rocket


News + Filings
Transactions
Holdings


All
13F
13D/G
Other

Belldegrun Arie Create: Alert

All | News | Filings
Date FiledTypeDescription
03/24/2023 4 Belldegrun Arie (Director) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Granted 1,282,976 shares @ $0
Granted 994,800 options to buy @ $5.04, valued at $5M
09/16/2022 4 Belldegrun Arie (Director) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Exercised 160,000 options to buy @ $5, valued at $800k
09/02/2022 4 Belldegrun Arie (Director) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Exercised 3,241 options to buy @ $5, valued at $16.2k
06/29/2022 4 Belldegrun Arie (Director) has filed a Form 4 on Kronos Bio, Inc.
Txns: Granted 34,000 options to buy @ $3.53, valued at $120k
06/13/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2022 4 Belldegrun Arie (Director) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Granted 10,000 options to buy @ $7.06, valued at $70.6k
03/31/2022 4 Belldegrun Arie (Director) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Disposed of 4,710,121 shares @ $0
Acquired 4,710,121 shares @ $0
03/25/2022 4 Belldegrun Arie (Director) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Granted 1,458,333 options to buy @ $9.69, valued at $14.1M
01/14/2022 4 Belldegrun Arie (Director) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Bought 155,039 shares @ $12.6, valued at $2M
06/23/2021 4 Belldegrun Arie (Director) has filed a Form 4 on Kronos Bio, Inc.
Txns: Granted 20,600 options to buy @ $24.18, valued at $498.1k
06/09/2021 4 Belldegrun Arie (Director) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Granted 10,000 options to buy @ $17.98, valued at $179.8k
05/25/2021 4 Belldegrun Arie (Director) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Exercised 379,066 options to buy @ $18.22, valued at $6.9M
04/22/2021 4 Belldegrun Arie (Director) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Exercised 3,241 options to buy @ $5, valued at $16.2k
03/30/2021 4 Belldegrun Arie (Director) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Granted 53,635 shares @ $0
Granted 199,223 options to buy @ $33.78, valued at $6.7M
10/16/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2020 4 Belldegrun Arie (Director) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Granted 10,000 options to buy @ $28.24, valued at $282.4k
06/04/2020 4 Belldegrun Arie (Director) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Bought 40,000 shares @ $47, valued at $1.9M
Bought 106,382 shares @ $47, valued at $5M
03/20/2020 4 Belldegrun Arie (Director) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Granted 379,066 options to buy @ $18.22, valued at $6.9M
06/05/2019 4 Belldegrun Arie (Director) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Granted 10,000 options to buy @ $34.83, valued at $348.3k
05/15/2019 4 Belldegrun Arie (Director) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Disposed of 598,935 shares @ $0
Acquired 13,413 shares @ $0
04/30/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/28/2019 4 Belldegrun Arie (Director) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Exercised 128,000 options to buy @ $4.02, valued at $514.6k
03/15/2019 4 Belldegrun Arie (Director) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Granted 115,333 shares @ $0
Granted 195,133 options to buy @ $26.89, valued at $5.2M
10/17/2018 4 Belldegrun Arie (10% Owner) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Bought 35,000 shares @ $18, valued at $630k
Converted 142,248 shares @ $0
Converted 5,989,352 shares @ $0
Converted 1,497,336 shares @ $0
Converted 27,095 convertible preferred @ $0
Converted 1,140,829 convertible preferred @ $0
Converted 285,207 convertible preferred @ $0
10/05/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/27/2017 4 Belldegrun Arie (Chairman, President and CEO) has filed a Form 4 on Kite Pharma, Inc.
Txns: Granted 50,000 shares @ $0
Sold 26,347 shares @ $179.6639, valued at $4.7M
05/09/2017 4 Belldegrun Arie (Chairman, President and CEO) has filed a Form 4 on Kite Pharma, Inc.
12/29/2016 4 Belldegrun Arie (Chairman, President and CEO) has filed a Form 4 on Kite Pharma, Inc.
12/22/2016 4 Belldegrun Arie (Chairman, President and CEO) has filed a Form 4 on Kite Pharma, Inc.
08/17/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
04/11/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
11/06/2013 4 Belldegrun Arie (Director) has filed a Form 4 on Arno Therapeutics, Inc
Txns: Granted 3,559,296 options to buy @ $2.4, valued at $8.5M
11/05/2013 4 Belldegrun Arie (Director) has filed a Form 4 on Arno Therapeutics, Inc
Txns: Converted 66,652 shares @ $2.4, valued at $160k
Granted 5,000 shares @ $2.4, valued at $12k
Bought 83,332 shares @ $0
Converted 88,871 shares @ $2.4, valued at $213.3k
Granted 6,666 shares @ $2.4, valued at $16k
Converted 62,500 options to buy @ $2.4, valued at $150k
Disposed/sold 62,500 options to buy @ $2.4, valued at $150k
Granted 62,500 options to buy @ $2.4, valued at $150k
Bought 83,333 options to buy @ $4, valued at $333.3k
Bought 83,333 options to buy @ $2.4, valued at $200k
Converted 83,333 options to buy @ $2.4, valued at $200k
11/05/2013 4 Belldegrun Arie (Director) has filed a Form 4 on Arno Therapeutics, Inc
Txns: Bought 104,166 shares @ $0
Converted 133,305 shares @ $2.4, valued at $319.9k
Granted 10,000 shares @ $2.4, valued at $24k
Bought 104,166 shares @ $0
Converted 155,523 shares @ $2.4, valued at $373.3k
Granted 11,666 shares @ $2.4, valued at $28k
Bought 187,500 shares @ $0
Bought 104,166 options to buy @ $4, valued at $416.7k
Bought 104,166 options to buy @ $2.4, valued at $250k
Converted 125,000 options to buy @ $2.4, valued at $300k
Disposed/sold 125,000 options to buy @ $2.4, valued at $300k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy